Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study

By sjmartinez • December 20, 2024

Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Burgoon R, Cifuentes R, Claeys KC, Curry BN, DeSear KE, Gallagher JC, Golnabi EY, Gross AE, Hand J, Heil EL, Hornback KM, Kaye KS, Khuu TV, Klatt ME, Kline EG, Kubat RC, Kufel WD, Lee JH, Lepak AJ, Lim A, Ludwig JM, Macdougall C, Majumdar A, Mathers AJ, McCreary EK, Miller WR, Monogue ML, Moore WJ, Olson S, Oxer J, Pearson JC, Pham C, Pinargote P, Polk C, Satlin MJ, Satola SW, Shah S, Tamma PD, Tran TT, van Duin D, VanNatta M, Vega A, Venugopalan V, Veve MP, Wangchinda W, Witt LS, Wu JY, Pogue JM; PRECEDENT Network. Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study. Lancet Infect Dis. 2024 Dec 16:S1473-3099(24)00648-0. doi: 10.1016/S1473-3099(24)00648-0. Epub ahead of print. PMID: 39701120.

Tags: Infectious Diseases, Publications

First Reported Case of Capnocytophaga cynodegmi Infective Endocarditis: A Diagnostic Odyssey

Tran LNB, Zhuo R, Singha M, Sekhon H, Yang S, Fishbein GA, Tymchuk C, Allyn PR. First Reported Case of Capnocytophaga cynodegmi Infective Endocarditis: A[...]

A 73-Year-Old Woman With a 7-Year History of a Slowly Growing Lung Mass and Hemoptysis Mimicking Malignancy

Qi L, Allyn Iii PR, Fishbein GA. A 73-Year-Old Woman With a 7-Year History of a Slowly Growing Lung Mass and Hemoptysis Mimicking Malignancy. Arch[...]

Impacts of neutralizing antibody responses on SARS-CoV-2 evolution and its associated disease progression

Wang L, Aliyari S, Sands N, Lee B, Yu A, Xia S, Jolkovsky EL, Zhang S, Kim J, Cheng G. Impacts of neutralizing antibody responses[...]